![Usefulness of Statins as Secondary Prevention Against Recurrent and Terminal Major Adverse Cardiovascular Events - ScienceDirect Usefulness of Statins as Secondary Prevention Against Recurrent and Terminal Major Adverse Cardiovascular Events - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0002914922004301-gr1.jpg)
Usefulness of Statins as Secondary Prevention Against Recurrent and Terminal Major Adverse Cardiovascular Events - ScienceDirect
![Association between statin exposure and short-term mortality in patients with high-grade acute-on-chronic liver failure - ScienceDirect Association between statin exposure and short-term mortality in patients with high-grade acute-on-chronic liver failure - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S258955592300071X-ga1.jpg)
Association between statin exposure and short-term mortality in patients with high-grade acute-on-chronic liver failure - ScienceDirect
![IJMS | Free Full-Text | Statins in High Cardiovascular Risk Patients: Do Comorbidities and Characteristics Matter? IJMS | Free Full-Text | Statins in High Cardiovascular Risk Patients: Do Comorbidities and Characteristics Matter?](https://pub.mdpi-res.com/ijms/ijms-23-09326/article_deploy/html/images/ijms-23-09326-g001.png?1660829137)
IJMS | Free Full-Text | Statins in High Cardiovascular Risk Patients: Do Comorbidities and Characteristics Matter?
![Study Explaining Side Effects of Statins Finds Drug Can Have Unexpected Benefits - Drug Discovery and Development Study Explaining Side Effects of Statins Finds Drug Can Have Unexpected Benefits - Drug Discovery and Development](https://drugdiscoverytrends.com/wp-content/uploads/2019/10/190320-statin.jpg)
Study Explaining Side Effects of Statins Finds Drug Can Have Unexpected Benefits - Drug Discovery and Development
Association between Statin Use and Short-Term Outcome Based on Severity of Ischemic Stroke: A Cohort Study | PLOS ONE
![Statins: a viable candidate for host-directed therapy against infectious diseases | Nature Reviews Immunology Statins: a viable candidate for host-directed therapy against infectious diseases | Nature Reviews Immunology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41577-018-0094-3/MediaObjects/41577_2018_94_Fig1_HTML.png)
Statins: a viable candidate for host-directed therapy against infectious diseases | Nature Reviews Immunology
![Cognitive performance of statin users with differently long treatment... | Download Scientific Diagram Cognitive performance of statin users with differently long treatment... | Download Scientific Diagram](https://www.researchgate.net/publication/340548131/figure/fig3/AS:959604859101185@1605799035225/Cognitive-performance-of-statin-users-with-differently-long-treatment-duration-compared.png)
Cognitive performance of statin users with differently long treatment... | Download Scientific Diagram
![Pharmaceuticals | Free Full-Text | Beyond Lipid-Lowering: Effects of Statins on Cardiovascular and Cerebrovascular Diseases and Cancer Pharmaceuticals | Free Full-Text | Beyond Lipid-Lowering: Effects of Statins on Cardiovascular and Cerebrovascular Diseases and Cancer](https://pub.mdpi-res.com/pharmaceuticals/pharmaceuticals-15-00151/article_deploy/html/images/pharmaceuticals-15-00151-g001.png?1643262731)
Pharmaceuticals | Free Full-Text | Beyond Lipid-Lowering: Effects of Statins on Cardiovascular and Cerebrovascular Diseases and Cancer
![WHAT ARE THE SHORT AND LONG TERM BENEFITS OF STATIN THERAPY INITIATED AROUND THE TIME OF INVASIVE PROCEDURES?: A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS | Journal of the American College of Cardiology WHAT ARE THE SHORT AND LONG TERM BENEFITS OF STATIN THERAPY INITIATED AROUND THE TIME OF INVASIVE PROCEDURES?: A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS | Journal of the American College of Cardiology](https://www.jacc.org/cms/asset/bc262d86-57d3-48d9-9b26-aa520bb351d1/s0735-1097(10)60483-4.fp.png)
WHAT ARE THE SHORT AND LONG TERM BENEFITS OF STATIN THERAPY INITIATED AROUND THE TIME OF INVASIVE PROCEDURES?: A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS | Journal of the American College of Cardiology
![Long-term efficacy and safety of moderate-intensity statin with ezetimibe combination therapy versus high-intensity statin monotherapy in patients with atherosclerotic cardiovascular disease (RACING): a randomised, open-label, non-inferiority trial ... Long-term efficacy and safety of moderate-intensity statin with ezetimibe combination therapy versus high-intensity statin monotherapy in patients with atherosclerotic cardiovascular disease (RACING): a randomised, open-label, non-inferiority trial ...](https://www.thelancet.com/cms/attachment/8a7a8c17-dc5a-4fd7-b99e-221ab660d8c1/gr1.gif)
Long-term efficacy and safety of moderate-intensity statin with ezetimibe combination therapy versus high-intensity statin monotherapy in patients with atherosclerotic cardiovascular disease (RACING): a randomised, open-label, non-inferiority trial ...
![In-hospital initiation of PCSK9 inhibitor and short-term lipid control in patients with acute myocardial infarction | Lipids in Health and Disease | Full Text In-hospital initiation of PCSK9 inhibitor and short-term lipid control in patients with acute myocardial infarction | Lipids in Health and Disease | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12944-022-01724-9/MediaObjects/12944_2022_1724_Fig1_HTML.png)